Latest Breaking News On - Acceleron pharma inc - Page 1 : comparemela.com

Head to Head Comparison: Fulcrum Therapeutics (NASDAQ:FULC) vs Cytokinetics (NASDAQ:CYTK)

Cytokinetics (NASDAQ:CYTK – Get Free Report) and Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation. Analyst Ratings This is a breakdown of current recommendations […]

United kingdomUnited statesSouth san franciscoAcceleron pharma incFulcrum therapeutics incCytokinetics incorporatedMyokardia incJi xing pharmaceuticalsGet free reportFulcrum therapeuticsGiven fulcrum therapeuticFulcrum therapeuticAcceleron pharmaCytokinetics daily

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

United statesSouth koreaPushkar muthaMariat bourlonTycel jovelle phillipsTony mokLin wangPeter robert galleCharlene mantiaMarc hoffmannEric christensonSuzanne trudelManali kirtikumar kamdarGuillermo garcia maneroMartin reckTina cascone

Invivyd Elects Two New Independent Members to its Board of Directors

WALTHAM, Mass., May 22, 2024 Invivyd, Inc. , a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that two new independent.

United kingdomClive meanwellMichaels wyzgaMarc eliaTom heymanSrishti guptaKevinf mclaughlinBoard of directors vericel corporationMckinsey companyChairperson of the compensation committeeRegeneron pharmaceuticalsBoard of directors at idorsia pharmaceuticalsNortheastern universityPharmaceuticals incorporatedHarvard kennedy school of governmentHarvard college

Invivyd, Inc Elects Two New Independent Members to its Board of Directors

Invivyd, Inc. announced that two new independent directors, Dr. Srishti Gupta and Kevin F. McLaughlin, were elected to its Board of Directors at the annual meeting of stockholders on May 21, 2024. Dr..

United kingdomKevinf mclaughlinSrishti guptaChairperson of the audit committeeHarvard graduate school of artsHarvard medical schoolNortheastern universityBoard of directors at idorsia pharmaceuticalsInvivyd incPharmaceuticals incorporatedMckinsey companyMerck co incHarvard collegeChairperson of the compensation committeeMckinsey global health practiceHarvard kennedy school of government

Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar

Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Rob davisPrometheus biosciences incAcceleron pharma incDaiichi sankyo coBloomberg merck coHarpoon therapeutics incDaiichi sankyoChief executive officer rob davisAcceleron pharma